
Mother of baby with spinal muscular atrophy wants all newborns to be tested for it
Chester was eight months old when his parents were finally told the condition that meant he couldn't swallow or move his legs and left him constantly distressed was spinal muscular atrophy, or SMA.
But it's a delay that will have a lifelong impact.
"He still can't hold his head up," said his mum, Kasey Mumford.
"If he'd been diagnosed by the heel prick test at like three or five days old, he could have started medication straight away, because there's a treatment for it, there are three different types of treatment, but there's no cure. He will never not have this."
Chester is nearly one now, but needs a ventilator at night to breathe.
But SMA isn't one of the 10 rare illnesses that newborn babies are currently tested for in the UK, unlike in the US and much of Europe.
Dr Vasantha Gowda, a consultant paediatric neurologist at London's St Thomas' Hospital, says clinicians from other countries are "all shocked that we don't have newborn screening for SMA".
"If we treat these children early, there is a possibility that… they would walk, run, climb, play. They would not need any support for breathing. They would need no support for feeding," she said.
"We know there's a potential to deliver this if the condition is picked up at the earliest possible stage."
SMA causes irreversible loss of motor neurons, which affects muscle function.
Nine out of 10 will either die before they're two or rely on a ventilator for life.
And when 2,000 parents were surveyed recently, 90% said they'd want to know as soon as possible if their child had SMA.
Four in every five wanted screening implemented immediately, and the same proportion considered the £5 cost per test good value.
The lack of testing for the condition is, according to the chief executive of the charity SMA UK, "unethical".
"The new 10-year NHS plan has highlighted that prevention is a key pillar," said Giles Lomax. "Newborn screening for SMA is essentially a very quick and easy win to align to that pillar.
"We've got the treatments there, we've got pathways, we have the expertise, we could make prevention for SMA a thing right now."
New therapies have been developed since SMA was last considered for inclusion, and in 2023, the UK National Screening Committee agreed to review the decision.
A large-scale study is now under way and the different governments across the UK have said they'll be guidedby the advisory body's recommendations.
But Chester's mum is clear that it must be included as "every single second counts" when it comes to receiving treatment.
Instead, for Kasey and her partner, Dylan, there will always be that uncertainty about what might have been had their boy been diagnosed sooner.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
24 minutes ago
- BBC News
Suffolk care provider rated as inadequate by watchdog
A care provider that looks after people with dementia, mental health conditions and physical disabilities has been rated inadequate by a health watchdog. Hearts of Care Agency, based in Ipswich, Suffolk, was placed into special measures by the Care Quality Commission (CQC).The CQC said the firm, which provides cares for 16 people in their own home, was inadequate for being safe, effective, responsive and well-led. Hearts of Care Agency said it was "disappointed" by the CQC's rating but would "learn from our mistakes". The firm being placed in special measures means the business will be closely monitored and a timeframe has been set out for improvements to be made, the CQC said. A report, which was published by the watchdog, stated that a condition was placed on Hearts of Care Agency when it registered with the CQC to not provide services for autistic adults or adults with a learning however, found that these services were being carried CQC inspection, which was carried out in May, also found that the firm was supporting children and younger adults with personal care when it was not registered to do so. Poor leadership Hazel Roberts, the CQC deputy director of operations in the East of England, said: "When we inspected the Hearts of Care Agency, we were concerned to find the service wasn't always meeting people's needs safely, because leaders weren't managing the service well."Leaders had not registered with CQC to care for children, young people, autistic people, or people with a learning disability, but were providing care to them anyways. "We were deeply concerned to find staff didn't always understand how best to support their individual needs or respect their rights." Mark Elvidge, the director of Hearts of Care Agency, said: "Following our recent assessment Hearts of Care Agency are extremely disappointed with our rating of inadequate. "We have happy clients and happy staff and view this rating as harsh and unfair."However, we will not be complacent about our failings. As a director, I take full responsibility, but I can assure our clients, staff, and public we will learn from our mistakes and shortcomings."He said the firm has a plan in place to make improvements before the next inspection in August. Follow Suffolk news on BBC Sounds, Facebook, Instagram and X.


BBC News
26 minutes ago
- BBC News
Medical trial for penis cancer 'gave me two more years'
A man who was the first to take part in a medical trial for penile cancer says it may have extended his life by two years. Eddie Baker, 83, was given immunotherapy alongside the usual treatment of chemotherapy as part of the clinical trial, named treatment was found to have extended the predicted lifespans of more than half of the participants in the study, which was carried out by University Hospitals Bristol and Weston NHS Foundation Baker, from Yate, South Gloucestershire, said: "All I can say is, it is the most wonderful thing that ever happened to me because I know if I hadn't had that, I would not be on this planet to this day." Mr Baker told the BBC his cancer had been caught late because it took over a year for him to come forward with his symptoms. The NHS says symptoms can include bleeding, a rash, a lump or growth, and a change in skin colour."It didn't look very good," Mr Baker said. "The actual swelling got bigger and bigger and then I was trying to get somewhere to get my life sorted out and find out what it was. It was too late."He had to have an amputation and has been left with incurable cancer. Consultant oncologist and chief investigator of the EPIC study, Professor Amit Bahl, said the stigma around such symptoms often leads to late said: "In cancers like these, there is no support system, you can't go out and talk about it because most patients have never heard you can get cancer in the penis. "If you ask ladies, they have heard about cancer in the cervix, in the vagina, but cancer in the penis never gets talked about."The immunotherapy treatment used in the trial is not available on the NHS, but Professor Bahl is applying to the Cancer Drugs Fund to pay for the small number patients who may benefit. Using immunotherapy to treat cancer is still considered by doctors to be a relatively new more than 60 per cent of the patients in the trial, who all had advanced penile cancer, were found to have had a clinical these patients, predicted lifespans increased to 15 months on Bahl said: "Our aim is to improve outcomes in this rare cancer, which has limited treatment options."Penile cancer can be a very aggressive disease, but this study shows we might be able to give men a little more time."Penile cancer is rare, and it usually presents externally first, so when patients are diagnosed, early treatments which can cure the cancer are possible."The trial has proved so successful that Professor Bahl is now planning to start another trial to give immunotherapy at an earlier stage of the disease, in the hope that it will improve cure rates.


BBC News
26 minutes ago
- BBC News
London baby banks issue plea for nappies amid shortage
Stocks of baby wipes and nappies for newborn babies have run out across a network of baby banks in London, a charity has warned. Little Village said that the essential items had run out across its hubs in Camden, Tooting and Brent and its Wandsworth warehouse. The charity, which supported 7,325 babies and children up to the age of five last year, reported that demand for its services was Compston, from Little Village, said: "Tomorrow a parent may have to choose between buying food or keeping their baby clean and dry – no family should face that kind of impossible decision. Nappies are not a luxury; they are a necessity." It is appealing for donations of newborn nappies, size one nappies and baby wipes at its charity said that it had provided 64% more packs of nappies in the first half of 2025 than in the same time period in 2024. Renata Acioli, a baby bank manager at Little Village, said: "I meet families who are doing everything they can but still don't have enough in their pockets to cover the most essential items for their baby."It breaks my heart hearing stories of mums and dads having to resort to nappy and formula rationing."On average, a newborn uses about 10 nappies a day, meaning families typically go through about three packs a week.